Showing results (11-20 of 99) with videos related to
Sort By:
Pageof 10
Rapid Communications in Mass Spectrometry : RCM|July 27, 2007
A liquid chromatography/atmospheric pressure ionization tandem mass spectrometry quantitation method for nevirapine and its two oxidative metabolites, 2-hydroxynevirapine and nevirapine 4-carboxylic acid, and pharmacokinetics in baboonsZhongfa Liu, Patty Fan-Havard, Zhiliang Xie, et al.Rapid Communications in Mass Spectrometry : RCM|April 3, 2003
Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the bloodJim J Xiao, John Byrd, Guido Marcucci, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2002
Chiral pharmacokinetics and inversion of enantiomers of a new quinoxaline topoisomerase IIbeta poison in the ratHui Zheng, Chun Jiang, Ming H Chiu, et al.Journal of Pharmaceutical and Biomedical Analysis|April 4, 2002
Chiral high-performance liquid chromatographic analysis of the enantiomers of XK469, a new antitumor agent, in plasma and urineHui Zheng, Joseph M Covey, Patricia J Tosca, et al.Journal of Pharmaceutical and Biomedical Analysis|November 10, 2004
An API LC/MS/MS quantitation method for ansamitocin P-3 (AP3) and its preclinical pharmacokineticsZhongfa Liu, Heinz G Floss, John M Cassady, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 23, 2005
Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometryGuowei Dai, Xiaohui Wei, Zhongfa Liu, et al.Molecular Pharmacology|May 23, 2003
DNA sequence specificity for topoisomerase II poisoning by the quinoxaline anticancer drugs XK469 and CQSHanlin Gao, Edith F Yamasaki, Kenneth K Chan, et al.Rapid Communications in Mass Spectrometry : RCM|March 9, 2006
Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification methodZhongfa Liu, Guido Marcucci, John C Byrd, et al.Cancer Chemotherapy and Pharmacology|November 27, 2002
Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the ratJing Liu, Eric H Kraut, Stanley Balcerzak, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2006
In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogsMinoli A Perera, Donghua Yin, Di Wu, et al.Pageof 10